查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1445531

全球乳房切片市场评估：按产品类型、应用、最终用户和地区划分的机会和预测（2017-2031）

Breast Biopsy Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 225 Pages | 商品交期: 3-5个工作天内

价格

全球乳房切片市场规模将从2023年的21.1亿美元成长到2031年的35.1亿美元，2024-2031年预测期间复合年增长率为6.58%，预计规模也将持续成长。

该市场的推动因素包括女性癌症发病率的增加、对微创手术的日益偏好、对癌症及其筛检方法、真空辅助活检、空芯针活检和立体定向活检的认识不断增强。预计这将受到活检技术和设备进步等因素的影响。

此外，政府和其他组织实施的各种计划预计将提高人们对癌症早期检测的认识，并积极影响对其诊断的需求。 近年来，开发癌症治疗药物和诊断解决方案的投资大幅增加，进一步扩大了市场规模。 世界卫生组织已确定乳癌是全世界最常被诊断的癌症类型，也是女性癌症相关死亡的主要原因。 50岁以上的女性更容易罹患乳癌，老年女性数量的增加使得盛行率不断上升。

另一方面，先进活检技术和设备的高成本是中低收入国家市场面临的主要挑战。 虽然乳房切片检查是一种微创手术，但存在感染和组织损伤的风险。 此外，患者的不适感也是采用乳房切片检查的障碍。 活检仪器製造的严格监管指南也是市场扩张的主要挑战。

癌症盛行率高

乳癌是女性最常被诊断出的癌症，也是全世界最常见的癌症类型。 由于生活方式的改变以及日常生活中接触辐射和致癌化学物质的增加，癌症的盛行率预计将进一步增加。 虽然遗传和家族史是癌症的主要因素，但越来越多地使用荷尔蒙避孕药来避免意外怀孕也是导致癌症盛行率上升的一个主要因素。

乳房切片检查方法的进展

虽然手术切除切片检查是以前唯一的选择，但现在有微创方法可用于诊断癌症。 向影像引导乳房切片检查方法的范式转变，如超音波引导活检、乳房X光摄影立体定位活检、磁振造影影像引导活检、断层合成引导活检和真空辅助活检等，将为进一步提高精准诊断打开可能性。 液体活检是一项透过分析血液样本来检测循环肿瘤细胞和游离 DNA 的新技术，这可能有助于诊断癌症和个人化预后。 真空辅助活检正在成为一种流行的选择，因为它对患者的创伤较小。 製造商正在透过开发创新解决方案来抓住市场机会。

本报告调查了全球乳房切片市场，并提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。我们编制分析、案例研究、竞争格局、主要公司简介等等。

目录

第 1 章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球乳房切片市场展望

  • 市场规模/预测
  • 依产品类型
    • 切片针
    • MRI引导切片系统
    • 超音波引导乳房切片系统
    • 真空辅助装置（VAD）
    • 导丝
    • 乳房切片标记
  • 依用途
    • 侵袭性癌症
    • 乳管原位癌
  • 按最终用户
    • 医院
    • 专科诊所
    • 门诊手术中心
    • 癌症研究
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 各公司的市占率

第 5 章全球乳房切片市场展望：按地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场映射

  • 依产品类型
  • 依用途
  • 按最终用户
  • 按地区

第 7 章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 生长抑制因素（问题、限制因素）

第 9 章监理架构与创新

  • 临床试验
  • 专利情况
  • 监理机关的核准
  • 创新/新兴技术

第 10 章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）

第 11 章案例研究

第 12 章主要公司展望

  • Becton, Dickinson and Company
  • Hologic Inc.
  • Danaher Corporation
  • Argon Medical Devices Inc.
  • Devicor Medical Products, Inc. (Mammotome)
  • Merit Medical Systems, Inc.
  • Qiagen NV
  • Cook Medical Inc.
  • OncoCyte Corporation
  • INRAD, Inc.

第 13 章策略建议

第 14 章关于我们公司/免责声明

Product Code: MX11080

Global breast biopsy market is projected to witness a CAGR of 6.58% during the forecast period, between 2024-2031, growing from USD 2.11 billion in 2023 to USD 3.51 billion in 2031F. The market is anticipated to be influenced by factors such as the growing prevalence of breast cancer among females, rising preference for minimally invasive procedures, growing awareness about breast cancer and its screening methods along with technical advancements in biopsy techniques and devices such as vacuum-assisted biopsy, core needle biopsy, and stereotactic-guided biopsy techniques.

Additionally, various programs run by governments and other organizations are expected to spread awareness about early detection of breast cancer, positively impacting the demand for its diagnostics. A significant rise in investments has been made in recent years to develop breast cancer therapeutics and diagnostics solutions, further expanding the market offerings. WHO confirms that most common type of cancer being diagnosed globally is breast cancer and it is also the leading cause of cancer related deaths among women. The increasing geriatric female population is adding more numbers to the prevalence, as women above the age of 50 years are highly prone to breast cancer.

However, the high cost associated with advanced biopsy procedures, and equipment poses a significant challenge for the market in low and middle-income countries. Despite being a minimally invasive procedure, breast biopsy procedures have the risk of infections and tissue damage. Alongside, patient discomfort is another factor posing limitations for the adoption of breast biopsies. Stringent regulatory guidelines for manufacturing biopsy instruments are another major challenge for market expansion.

In August 2023, Mammotome released a new breast biopsy site marker called HydroMARK Plus, which is designed to improve ultrasound visibility, ease of locating, and prevent displacement during surgical procedures. The HydroMARK Plus Breast Biopsy Site Marker is anticipated to be be available to healthcare professionals in the United States by the end of 2023, and company haveplans to expand the market to Canada and some other selected countries worldwide.

High Prevalence of Breast Cancer

Breast cancer is the most commonly diagnosed cancer type in women and the most common cancer type among all types of cancers globally. With changing lifestyles and increasing exposure to radiation and carcinogenic chemicals in day-to-day life, the prevalence of breast cancer is anticipated to increase further. Genetics and family history of breast cancer is a dominating factor while increasing use of hormone-based contraceptives in females to avoid unwanted pregnancies is another major factor contributing to the rising prevalence of breast cancer.

Although breast cancer mainly occurs in females, around 0.5-1% of breast cancer cases are diagnosed in men, which may occur due to hormonal imbalance or other reasons. Physical examination of breasts is a preliminary diagnostic method, but confirmation is done by biopsy method with high precision. The high prevalence is anticipated to significantly increase the demand for breast biopsy equipment and procedures in the assessment period.

As per the American Cancer Society, incidence rates of breast cancer in the United States have increased by 0.6% per year. The rise in incidence rates is steeper in women younger than 50 years (1.0%). WHO estimates around 685,000 annual death cases due to breast cancer globally.

Advancements in Breast Biopsy Methods

Previously, surgical excisional biopsy was the single alternative, but presently there are minimally invasive procedures available for diagnosis of breast cancer. The paradigm shift towards image-guided breast biopsy methods, such as ultrasound-guided biopsy mammographic stereotactic biopsy, magnetic resonance imaging-guided biopsy, tomosynthesis-guided biopsy, and vacuum-assisted biopsy have opened further opportunities for precision diagnostics. Liquid biopsy is a newer technique that involves analyzing blood samples to detect circulating tumor cells or cell-free DNA, which may help personalize breast cancer diagnosis and prognosis. Vacuum-assisted biopsy is becoming a popular choice due to lesser trauma to patients. Manufacturers are encashing market opportunities by producing innovative solutions.

For instance, in December 2023, Exai Bio announced new data that its AI-driven liquid biopsy test can detect breast cancer at early stages and small tumor sizes, including DCIS, using a standard blood sample. In a recent study, the test showed 87% sensitivity for stage I breast cancer and 81% for tumors =10mm at 90% specificity. Overall sensitivity was 88% for invasive breast cancer stages, outperforming any DNA-based liquid biopsy. The sensitivity for DCIS was 78%. These findings are being presented at the San Antonio Breast Cancer Symposium (SABCS), 2023.

Dominance of Biopsy Needle Segment

The biopsy needle segment is anticipated to dominate the breast biopsy market with the highest share. The dominance of biopsy needles in breast biopsy procedures can be attributed to their cost efficiency and research-based efficacy. A study comparing image-guided and palpation-guided core needle biopsies of palpable breast masses. It found that image-guided biopsies were considered more accurate than palpation-guided biopsies, with image-guided biopsies being preferred for sampling breast masses, even if they are palpable. The research suggests that core needle biopsy, especially when guided by imaging, is preferred for its accuracy and safety in diagnosing breast lesions. Biopsy needles are hollow needle instruments used to collect tissues from the breast and analyze them. These instruments are easy to handle and are thus preferred by professionals.

For instance, in February 2024, NeoDynamics received clearance (US plate_number_1(k)) for their innovative breast biopsy system, NeoNavia. This groundbreaking technology utilizes a patented pulse system to provide accurate and controlled needle insertion, based on research carried out at Karolinska Institutet. The system comprises of a base unit, a handheld driver, and three distinct biopsy needles. The pulse technology delivers precise needle placement within the tumor, allowing for high-quality tissue samples from both breasts and lymph nodes.

Invasive Breast Cancer to Dominate the Market

Invasive breast cancer spreads into the surrounding breast tissues, it can be of two types, invasive ductal carcinoma and invasive lobular carcinoma. Due to the high prevalence of these types of breast cancer, the related segment is anticipated to dominate the breast biopsy market. Another reason can be the widespread application of biopsy in deeper tissue extraction in case of invasive types of cancer. As per the American Cancer Society, invasive (or infiltrating) breast cancer is the most common type and within it, Invasive ductal carcinoma makes up about 70-80% of all breast cancers.

The American Cancer Society estimates that about 310,720 new cases of invasive breast cancer will be diagnosed in women in 2024 in the United States and about 56,500 new cases of ductal carcinoma in situ (DCIS) are expected to be diagnosed. Another estimate states that approximately 13% (about one in eight) of women in the United States are going to develop invasive breast cancer during their lives.

North America to be the Dominating Region

North America, particularly the United States and Canada, exhibits a notable prevalence of breast cancer, which can be attributed to several factors. The region has well-established screening programs that detect breast cancer at early stages, leading to higher diagnosis rates. Also, changes in risk factors, such as increased obesity and physical inactivity, have contributed to higher breast cancer rates. Socioeconomic factors, including access to healthcare and lifestyle choices, play a role in breast cancer prevalence. Additionally, genetic factors, like the presence of BRCA1 and BRCA2 mutations, are more common in North America, contributing to higher breast cancer rates. Despite these factors, breast cancer mortality rates have been declining in North America, which may be due to improved detection and treatment. With such factors, North America is expected to lead in the demand for breast biopsy methods.

For example, as per the statistics by the Centers for Disease Control and Prevention, about 240,000 cases of breast cancer per year are diagnosed in women and about 2,100 cases of breast cancer in men in the United States only. About 42,000 women and 500 men die from breast cancer in the United States every year. Within these statistics, the number of black women is higher as they are genetically more prone to breast cancer as compared to other races..

Future Market Scenario

Advancements in imaging techniques have led to enhanced tissue visualization and improved efficacy of biopsy methods, promising a bright future for the breast biopsy market. Novel techniques such as multiparametric MRI, photoacoustic imaging, and virtual biopsy provide advanced diagnostic insights. Imaging-guided therapies and theragnostic promise targeted precision treatment, revolutionizing the future of breast radiology. Similar to other domains, the integration of artificial intelligence in biopsy methods is another promising advancement that is anticipated to contribute to the market expansion.

For instance, in November 2023, Syantra, a company that specializes in liquid biopsy platforms and innovation, announced the expansion of its Intellectual Property (IP) portfolio and a strategic partnership with Limmi which is a US-based technology company. Limmi focuses on AI-driven insights to facilitate the development of next-generation techniques for disease detection and management. These achievements are major milestones for Syantra and represent significant advancements in the understanding of human diseases, starting with Syantra DX Breast Cancer.

Key Players Landscape and Outlook

The key players in the breast biopsy market include a variety of players ranging from multi-billion dollar companies to small startups. Some of the major players in global breast biopsy market are Becton, Dickinson and Company, Hologic Inc., Danaher Corporation, Argon Medical Devices, and Devicor Medical Products, Inc. (Mammotome). These players are constantly involved in innovation and R&D to cater to the demand for breast biopsy products. Market tactics like mergers and acquisitions, and collaborations have been significant contributors to the market expansion.

In April 2023, Quest Diagnostics announced a definitive agreement to acquire Haystack Oncology in an all-cash equity transaction. Quest Diagnostics is the United States' leading provider of diagnostic information services, and Haystack Oncology is an early-stage oncology company dedicated for testing of minimal residual cancer cells which helps in the early andaccurate detection of residual or recurring cancers, such as in the case of breast cancer, to provide better-informed therapy decisions.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Breast Biopsy Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Biopsy Needle
      • 4.2.1.1. Core Needles
      • 4.2.1.2. Fine Aspiration Needles
    • 4.2.2. MRI-Guided Biopsy Systems
    • 4.2.3. Ultrasound Guided Breast Biopsy Systems
    • 4.2.4. Vacuum-Assisted Device (VAD)
    • 4.2.5. Guide Wire
    • 4.2.6. Breast Biopsy Marker
  • 4.3. By Application
    • 4.3.1. Invasive Breast Cancers
    • 4.3.2. Ductal Carcinoma In Situ
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Specialty Clinics
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Cancer Research Institutes
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Breast Biopsy Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Biopsy Needle
      • 5.1.2.1.1. Core Needles
      • 5.1.2.1.2. Fine Aspiration Needles
      • 5.1.2.2. MRI-Guided Biopsy Systems
      • 5.1.2.3. Ultrasound Guided Breast Biopsy Systems
      • 5.1.2.4. Vacuum-Assisted Device (VAD)
      • 5.1.2.5. Guide Wire
      • 5.1.2.6. Breast Biopsy Marker
    • 5.1.3. By Application
      • 5.1.3.1. Invasive Breast Cancers
      • 5.1.3.2. Ductal Carcinoma In Situ
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals
      • 5.1.4.2. Specialty Clinics
      • 5.1.4.3. Ambulatory Surgical Centers
      • 5.1.4.4. Cancer Research Institutes
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product Type
      • 5.1.5.2.1. Biopsy Needle
      • 5.1.5.2.1.1. Core Needles
      • 5.1.5.2.1.2. Fine Aspiration Needles
      • 5.1.5.2.2. MRI-Guided Biopsy Systems
      • 5.1.5.2.3. Ultrasound Guided Breast Biopsy Systems
      • 5.1.5.2.4. Vacuum-Assisted Device (VAD)
      • 5.1.5.2.5. Guide Wire
      • 5.1.5.2.6. Breast Biopsy Marker
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Invasive Breast Cancers
      • 5.1.5.3.2. Ductal Carcinoma In Situ
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Specialty Clinics
      • 5.1.5.4.3. Ambulatory Surgical Centers
      • 5.1.5.4.4. Cancer Research Institutes
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.4.7. Supplier Power
    • 7.4.8. Buyer Power
    • 7.4.9. Substitution Threat
    • 7.4.10. Threat from New Entrant
    • 7.4.11. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Case Studies

12. Key Players Outlook

  • 12.1. Becton, Dickinson and Company
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products & Services
    • 12.1.4. Financials (As reported)
    • 12.1.5. Key Market Focus & Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Hologic Inc.
  • 12.3. Danaher Corporation
  • 12.4. Argon Medical Devices Inc.
  • 12.5. Devicor Medical Products, Inc. (Mammotome)
  • 12.6. Merit Medical Systems, Inc.
  • 12.7. Qiagen NV
  • 12.8. Cook Medical Inc.
  • 12.9. OncoCyte Corporation
  • 12.10. INRAD, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Breast Biopsy Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Breast Biopsy Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 16. United States Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 21. Canada Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Mexico Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Europe Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Breast Biopsy Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 37. Germany Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 42. France Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 43. France Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Italy Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 52. United Kingdom Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 57. Russia Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 62. Netherlands Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Spain Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Turkey Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Poland Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 82. South America Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Breast Biopsy Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 88. Brazil Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Argentina Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Asia-Pacific Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Breast Biopsy Market Share (%), By Country, 2017-2031F
  • Figure 101. India Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 104. India Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 105. India Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 109. China Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 110. China Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 114. Japan Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 119. Australia Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 124. Vietnam Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 129. South Korea Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Indonesia Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 139. Philippines Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 144. Middle East & Africa Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Breast Biopsy Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 150. Saudi Arabia Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 155. UAE Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Breast Biopsy Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Breast Biopsy Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Breast Biopsy Market Share (%), By Product Type, 2017-2031F
  • Figure 160. South Africa Breast Biopsy Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Breast Biopsy Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023